Personalized blood-thinner plan for leg artery disease after repair
Official title: Personalizing Post Surgical Thromboprophylaxis for Patients With Peripheral Artery Disease
Run by Massachusetts General Hospital · NCT07613840 · Data updated 2026-11-12
A personalized plan using a blood test to tailor antiplatelet therapy is being tested against standard treatment in adults with PAD after a procedure to restore blood flow.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 484 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 2 sites (Boston, Massachusetts and 1 other locations) |
| Status | Recruiting |
| Started | April 29, 2025 |
| Main results expected | April 29, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07613840 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with PAD who have undergone a revascularization procedure.
✕Probably not a fit
Patients whose coagulation profile does not differ meaningfully from standard treatment or who cannot tolerate the personalized regimen may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests whether a TARGET plan that uses thromboelastography with platelet mapping (TEG-PM) to customize antiplatelet therapy improves outcomes after lower-extremity revascularization for PAD. Participants are randomized to the personalized plan or standard treatment and receive blood tests at 1 week and at 1, 3, 6, 9, and 12 months to guide medication adjustments. The study looks at whether the personalized approach reduces graft/stent thrombosis, amputation, repeat procedures, bleeding, and death over 12 months. TEG-PM provides real-time profiling of coagulation and platelet response to antiplatelet drugs to inform therapy changes. Preliminary data suggest significant variability in platelet inhibition among PAD patients, supporting the need for individualized thromboprophylaxis.
Why it matters
Potential benefit: If successful, the personalized plan could lower clotting-related complications and improve limb-sparing outcomes.
How similar studies have gone: Prior observational data indicate platelet inhibition variability in PAD; whether a targeted approach improves outcomes remains to be proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a named arterial extremity injury or named vessel revascularization for atherosclerosis requiring open and/or closed revascularization. * Patients at the age of 18 or older Exclusion Criteria: * Patients who are younger than 18 years old * Known pregnancy (females of childbearing potential will have a pregnancy test prior to surgery as per standard of care) * Prisoners, defined as those who have been directly admitted from a correctional facility. * No atherosclerosis * Subject has active stomach ulcers * Subject has severe hepatic impairment * Subject has a recent history of intracranial hemorrhage. If the patient has a history of cerebral hemorrhage with no new central nervous system disease of \>1 year, the study team will consult with the
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting -
Salem Hospital (Mass General Brigham)
Salem, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Anahita Dua, MBCHB, MBA, MSC
- Email: adua1@mgh.harvard.edu
- Phone: 262-565-8247
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing powered and mechanical prosthetic knees for K2-level amputees
This study is testing whether powered prosthetic knees work better than mechanical ones for K2-level amputees to help improve their mobility and make better choices for future prosthetic designs.
-
Effect of EMG sensor number and placement on control of below-elbow prosthetic arms
This project will test whether changing the number and placement of myoelectric sensors helps adults with below-elbow limb absence control a prosthetic arm better while wearing a real device.
-
Microprocessor-controlled prosthetic knees for limited community ambulators with above-knee amputation.
This test will see if switching to a microprocessor-controlled prosthetic knee reduces fall-related health problems and improves walking speed, mobility, and quality of life for adults with above-knee amputations who are limited community ambulators compared with non-microprocessor knees.
-
Understanding the impact of powered prosthetics on walking for transfemoral amputees
This study is testing whether powered knee and ankle prosthetics can help transfemoral amputees walk better, especially when combined with special training.
-
Evaluation of a new myoelectric prosthesis for transradial amputees
This study is testing a new type of prosthetic arm that uses a special implant to help people with below-the-elbow amputations control it more easily and naturally.
-
Hand prosthesis usability and performance evaluation for people with upper limb absence
This study tests a new multi-articulating hand prosthesis to see if it performs better or differently than a participant’s own prosthesis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.